Trademark: 98125249
Word
CLARITAS RX
Status Date
Monday, September 2, 2024
Filing Date
Wednesday, August 9, 2023
Published for Opposition
Tuesday, October 8, 2024
42 Software as a service (SAAS) services featuring software to aggregate and process data, generate and share information and reports in the field of pharmaceuticals, and provide advanced predictive analytics to support patient accessibility to pharmaceuticals, pharmaceutical contracting, patient services insights, and medication payer insights, and commercial operations for pharmaceutical companies for use in developing strategies for commercialization of products and services within the field of biopharmaceuticals
The mark consists of the wording "CLARITAS RX" with the letter "C" and "R" capitalized; to the left of the wording appears a stylized image of a diamond.
as to "RX" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
Color is not claimed as a feature of the mark.
"RX"
Apr 9, 2024
Assigned To Examiner
Aug 12, 2023
New Application Entered
Sep 10, 2023
New Application Office Supplied Data Entered
Sep 12, 2023
Notice Of Design Search Code E-Mailed
Apr 10, 2024
Non-Final Action E-Mailed
Apr 10, 2024
Non-Final Action Written
Apr 10, 2024
Notification Of Non-Final Action E-Mailed
Jun 21, 2024
Teas Response To Office Action Received
Jun 21, 2024
Correspondence Received In Law Office
Jul 15, 2024
Notification Of Non-Final Action E-Mailed
Aug 29, 2024
Examiners Amendment -Written
Aug 29, 2024
Examiners Amendment E-Mailed
Aug 29, 2024
Notification Of Examiners Amendment E-Mailed
Jun 22, 2024
Teas/Email Correspondence Entered
Jul 15, 2024
Non-Final Action E-Mailed
Jul 15, 2024
Non-Final Action Written
Aug 29, 2024
Approved For Pub - Principal Register
Aug 29, 2024
Examiner's Amendment Entered
Sep 18, 2024
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
